VEGFA and neoplasm: Targets for this family of drugs are membrane receptors such as the fibroblast growth factor receptor (FGFR) and vascular endothelium growth factor receptor (VEGFR), intracellular kinases in tumor cells such as RET, or the vascular endothelial growth factor (VEGF) itself [10, 11, 22].